Top Pharmaceutical Exporters in India: A Buyer's Guide
You are comparing Indian pharmaceutical exporters and every website says the same three things. This guide does it differently: the verification checks that actually separate suppliers, and honest profiles of eight real exporters, including where we think each one genuinely fits. Yes, M Care is on the list; we have marked our entry clearly and held it to the same standard.
By Dr Rajat Bhatt · 2026-07-18 · Every company fact below is drawn from the company's own published materials or an official registry, and attributed as such.
How to evaluate an Indian pharmaceutical exporter before you shortlist anyone.
Valid Importer-Exporter Code (IEC) issued by DGFT
No person can export from India without an IEC unless specifically exempted. It is the baseline legal identity of any genuine Indian exporter, tied to the firm's PAN and a verifiable business address. A supplier who cannot produce a verifiable IEC is not a lawful exporter at all. How to check: Ask for the IEC certificate and verify it on the Directorate General of Foreign Trade portal (dgft.gov.in) using the IEC verification service under Services. Newer IEC certificates carry a QR code that resolves to the DGFT record. Confirm the legal entity name and address on the IEC exactly match the name on the quotation and export documents.
State Wholesale Drug Licence (Forms 20B and 21B) for the trading entity
A merchant exporter or trading house must itself be licensed to stock and sell drugs wholesale under the Drugs and Cosmetics Act, 1940 and Rules, 1945. Form 20B covers drugs other than Schedules C/C(1)/X; Form 21B covers Schedule C/C(1) drugs (injectables and biologicals). A trader shipping injectables who holds only a 20B, or no licence, is operating outside its authorisation. How to check: Request copies of the Form 20B and 21B licences and note the licence numbers, the issuing State Licensing Authority (the state FDA / Drugs Control Department, e.g. Maharashtra FDA), and the licensed premises address. Verify the licence number with that State Licensing Authority; several states (and the ONDLS national licensing portal) allow online licence lookup. Check the licence premises match the exporter's claimed warehouse and that the product categories quoted fall within the licence scope.
Pharmexcil membership (RCMC)
The Foreign Trade Policy requires pharmaceutical exporters to hold a Registration-cum-Membership Certificate from Pharmexcil (Pharmaceuticals Export Promotion Council of India, set up in 2004 under the Ministry of Commerce & Industry) to claim export benefits and obtain Certificates of Origin. RCMC membership signals the firm is a recognised, currently registered pharma exporter rather than a general trader. How to check: Ask for the RCMC certificate (issued by Pharmexcil, now processed through DGFT's e-RCMC common digital platform) and check the validity date, since RCMCs must be current. Confirm the membership with Pharmexcil (pharmexcil.com) via its member search or by emailing Pharmexcil with the membership number. The RCMC is also linked in the exporter's DGFT IEC profile.
Certificate of Pharmaceutical Product (CoPP) for the specific product, properly legalised
The CoPP, issued under the WHO Certification Scheme on the Quality of Pharmaceutical Products Moving in International Commerce, is the document most importing regulators require for registration. It confirms the product is approved and manufactured under GMP in India, and it names both the product and the manufacturing site, which makes it the single best cross-check on a trading house's supply chain claims. How to check: Ask for the CoPP for your exact product and strength. In India CoPPs are issued by CDSCO zonal/sub-zonal offices on behalf of the Drugs Controller General (India) after joint inspection and are valid for 2 years; applications are now routed through the ONDLS portal. Verify authenticity with the issuing CDSCO zonal office (cdsco.gov.in lists zonal contacts), check it has not expired, and confirm the manufacturing site named on the CoPP matches the site named on your CoA and cartons. For most markets, require apostille (Hague Convention, via MEA India) or embassy legalisation of the CoPP and ask which the exporter routinely arranges.
WHO-GMP status correctly attributed to the manufacturing site, not the trading house
WHO-GMP certification attaches to a specific manufacturing site and its inspected product lines. A merchant exporter cannot itself be 'WHO-GMP certified'; a trading house claiming WHO-GMP in its own name is either sloppy or misleading. Correct attribution is a fast integrity test of any Indian trading partner. How to check: Ask the exporter to name the actual manufacturer and site for each product and to provide that manufacturer's WHO-GMP certificate (issued by the CDSCO/State Licensing Authority after joint inspection, normally 2-year validity, site-specific and product-list-specific). Cross-check the site address against the CoPP and the batch CoA. If the product is claimed to be WHO-prequalified, verify the product-plus-site combination on the WHO Prequalification database (extranet.who.int/prequal); WHO PQ is product- and site-specific, never company-wide.
Clean regulatory standing with CDSCO and importing-country authorities
CDSCO publishes monthly Not of Standard Quality (NSQ) / spurious drug alert lists, and importing regulators (US FDA, EMA/EDQM, MHRA, WHO) publish warning letters, import alerts and notices of concern. A supplier or its manufacturers appearing on these lists is a direct product-quality and registration risk. How to check: Search the exporter's name and each disclosed manufacturer on cdsco.gov.in (NSQ drug alerts under the Drugs section), the US FDA import alert and warning letter databases, the EudraGMDP non-compliance database, and WHO's Medical Product Alerts on who.int. Repeat the check periodically, not just at onboarding.
Batch-specific Certificate of Analysis (CoA) against a stated pharmacopoeia, with independent retest option
The CoA is the batch-level quality evidence: assay, impurities, dissolution, sterility/endotoxin where applicable, tested against IP/BP/USP/Ph.Eur. as claimed. Traders sometimes forward manufacturer CoAs with mismatched batch numbers or missing pages; the CoA must trace to the exact batch and site you receive. How to check: Before payment of balance, require the manufacturer-issued CoA for the specific batch numbers shipped, and match batch number, manufacturing/expiry dates and manufacturing site against the CoPP, packing list and carton photos. Agree contractually on the governing pharmacopoeia. For first shipments, retain samples and commission an independent retest at an accredited laboratory (ISO/IEC 17025-accredited, or your national control lab) and make acceptance conditional on it.
Clear Incoterms 2020 terms and staged, documented payment terms
Ambiguity over who owns risk in transit (EXW vs FOB vs CIF/CIP) and 100%-advance demands are two of the most common commercial failure points with new suppliers. CIP with insurance to destination is generally safer for pharma; payment should be staged against documents, not trust. How to check: Require the quotation to state a specific Incoterms 2020 rule with named port/place, and who insures the goods in transit. For first orders prefer an irrevocable Letter of Credit or partial advance with balance against shipping documents (bill of lading/airway bill, CoA, CoPP, insurance certificate, certificate of origin from Pharmexcil or chamber of commerce). Confirm the beneficiary bank account name matches the IEC legal entity, and cross-check the firm's GSTIN on the GST portal (gst.gov.in) for extra identity assurance.
Validated cold-chain capability for temperature-sensitive products
For 2-8 C biologicals, insulins, vaccines and many injectables, the exporter's real capability is lane-level: qualified packaging, data loggers, and a plan for excursions. WHO's Model Guidance for time- and temperature-sensitive pharmaceutical products (WHO TRS 961 Annex 9) and Good Distribution Practice are the reference standards. How to check: Ask for evidence of shipping-lane or packaging qualification (summer/winter profiles), the make of calibrated temperature data loggers included in each shipment, and sample logger downloads from past shipments to your region. Require the contract to define the acceptable range, logger review at arrival, and rejection/replacement terms for excursions. Check whether packaging is WHO PQS-listed or equivalently qualified, and whether the named freight forwarders have pharma cold-chain handling (e.g. IATA CEIV Pharma) at the transit airports.
Registration dossier (CTD/eCTD) support for your market
If you must register the product with your national regulator, you need the manufacturer's dossier in CTD or eCTD format (the ICH Common Technical Document structure most authorities and the WHO prequalification programme use), plus ongoing support: samples, stability updates in your climatic zone (e.g. Zone IVb for hot/humid markets), and timely response to regulator queries. A trader without dossier access from its manufacturers cannot get you registered. How to check: Ask which of your target-market registrations the exporter has already supported and request the dossier table of contents (Modules 1-5) for your product before committing. Confirm in writing that the manufacturer will issue a Letter of Access/authorisation, provide stability data for your climatic zone, and answer deficiency letters within defined timelines. Verify at least one claimed registration directly with that country's regulator or its public register.
Verifiable export track record and independent references
Years of operation, markets served and repeat customers are the practical predictor of delivery reliability. Certificates prove legality; references prove performance on lead times, documentation accuracy and post-shipment support. How to check: Ask for 2-3 importer references in markets with regulatory rigour comparable to yours and contact them directly about documentation quality, cold-chain performance and complaint handling. Cross-check claimed shipment history against India customs shipment data (available via commercial trade-data providers built on Indian customs records) and the firm's incorporation record on the Ministry of Corporate Affairs portal (mca.gov.in) for company age and directors. Start with a small trial order regardless of how strong the paper trail looks.
What every legitimate exporter must hold, whoever you choose.
- An Importer-Exporter Code (IEC) issued by the Directorate General of Foreign Trade (DGFT, Ministry of Commerce & Industry) is mandatory for any export from India; no export or import may be made without one unless specifically exempted. PAN, a bank account and a valid firm address are prerequisites, DGFT may physically verify the address, and any IEC can be verified online on dgft.gov.in (newer certificates carry a verification QR code).
- Under India's Foreign Trade Policy, pharmaceutical exporters must hold a Registration-cum-Membership Certificate (RCMC) from Pharmexcil (Pharmaceuticals Export Promotion Council of India), the export promotion council set up in 2004 under the Ministry of Commerce & Industry. The RCMC is applied for against an active IEC (now via DGFT's e-RCMC platform), is time-limited and renewable, and Pharmexcil also issues Certificates of Origin. Pharmexcil's remit covers bulk drugs/APIs, formulations, biotech, herbal/AYUSH products and diagnostics.
- Domestic wholesale dealing in drugs requires a Wholesale Drug Licence from the State Licensing Authority (state FDA/Drugs Control Department) under the Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945: Form 20B for drugs other than Schedules C, C(1) and X, and Form 21B for Schedule C/C(1) drugs (which include injectables and biologicals). Applications are made on Form 19; licences granted are subject to periodic compliance assessment (not less than once every 3 years under the perpetual-licence regime). A merchant exporter trading in medicines needs these licences in its own name for its stocking premises.
- The Certificate of Pharmaceutical Product (CoPP) is issued in India under the WHO Certification Scheme on the Quality of Pharmaceutical Products Moving in International Commerce. CoPPs are issued by CDSCO zonal/sub-zonal offices on behalf of the Drugs Controller General (India) after scrutiny and joint inspection, are valid for 2 years, name the specific product and manufacturing site, and applications are now filed through the Online National Drugs Licensing System (ONDLS) portal.
- WHO-GMP certification in India is granted per manufacturing site (with an annexed product list) after joint CDSCO/State Licensing Authority inspection, and typically carries 2-year validity. It attaches to the manufacturer's site only: a merchant exporter or trading house cannot itself hold WHO-GMP, and its role is to disclose the manufacturer and pass through the site's WHO-GMP certificate and CoPP. Separately, WHO Prequalification is a product-plus-site listing verifiable on the public WHO PQ database (extranet.who.int/prequal), not a company-wide status.
- The Central Drugs Standard Control Organisation (CDSCO), headed by the Drugs Controller General (India) under the Ministry of Health & Family Welfare, is India's national drug regulatory authority (cdsco.gov.in). It approves new drugs, oversees imports, coordinates with State Licensing Authorities who issue manufacturing and sale licences, publishes monthly Not of Standard Quality (NSQ) and spurious-drug alert lists, and its zonal offices handle export-related certifications such as CoPPs and export NOCs.
- India's GMP baseline is Schedule M of the Drugs and Cosmetics Rules; the revised Schedule M (notified December 2023) aligns Indian GMP requirements substantially with WHO-GMP standards and is being enforced in phases by manufacturer turnover, so 'Schedule M compliant' and 'WHO-GMP certified' are converging but remain distinct claims to verify separately.
- The dossier format accepted by most importing regulators and the WHO Prequalification programme is the ICH Common Technical Document (CTD/eCTD, Modules 1-5); stability data must match the importing market's ICH climatic zone (e.g. Zone IVb for hot/humid countries), and the dossier and Letters of Access originate from the manufacturer, which is why dossier support must be contractually secured when buying through a trading house.
- For temperature-sensitive pharmaceuticals, the reference standards are WHO's Model Guidance for the storage and transport of time- and temperature-sensitive pharmaceutical products (WHO Technical Report Series 961, Annex 9) and Good Distribution Practice; WHO also maintains the PQS (Performance, Quality and Safety) catalogue of prequalified cold-chain equipment and packaging.
For the fuller verification walkthrough, see our guide: how to verify an Indian pharmaceutical exporter before you pay.
Eight Indian pharmaceutical exporters, and where each genuinely fits.
Listed alphabetically. Facts are from each company's own site or official registries; descriptions of fit are our editorial reading as a fellow exporter, kept deliberately neutral.
1. Actiza Pharmaceutical
Surat, Gujarat (411 Royal Square, Utran, Surat, per its site) · Describes itself as a supplier and wholesaler and as a "manufacturing and exporting expert" (per its site), i.e. manufacturing plus supply and distribution
Broad generics portfolio across roughly 100+ product categories listed on its site, including HIV/AIDS, anti-cancer, diabetes care, asthma/respiratory, women's health, erectile dysfunction, and life-saving drugs (per actizapharmaceutical.com) WHO-GMP compliant facilities, ISO certification, FDCA, Government Recognised Star Export House, Pharmexcil (all as claimed or displayed on actizapharmaceutical.com) Very wide catalogue breadth with bulk wholesale and distributor programs; buyers looking for one Gujarat-based counterparty covering many therapy areas in a single order would shortlist them Typical markets: Presence in 40+ countries per its site; a US toll-free line is prominently displayed, suggesting North America focus alongside other export markets.
2. GNH India
Mumbai, Maharashtra · 2003 (stated on gnhindia.com/about-gnh/; self-claim, verified as present on the site) · Merchant wholesaler / global pharmaceutical distributor (sourcing and supply); per its site it also offers contract manufacturing through WHO-GMP, US FDA and UK MHRA approved partner facilities
Orphan drugs, comparator medications, clinical trial supplies (comparator drugs, rescue medications, co-medications, investigational products), and named-patient program medicines; rare-disease access support (all per its own site) WHO-GDP certified, ISO 9001:2015, Maharashtra FDA drug license, DGFT IEC holder, SGS GSDP compliant; member of Pharmexcil and FIEO (all as claimed on gnhindia.com) Deep specialty-access catalogue: its site cites 235,000+ product lines supplied, with comparator drug sourcing for clinical trials and named-patient/orphan-drug supply; buyers typically shortlist them for comparator and hard-to-source specialty medicines with supporting documentation Typical markets: Claims supply to more than 180 countries (per its site).
3. Kachhela Medex
Nagpur, Maharashtra (Ganjipeth / Itwari addresses published on its own sites) · Wholesale trader / merchant-exporter; its own site describes it as an "Exporter and Dropshipper of Pharmaceutical Products"
Generic and branded medicines including anti-cancer/oncology lines and specialty drugs, traded wholesale and shipped internationally (per kachhelamedex.com and medicinesdropshipper.com) Publishes its GST registration and Import Export Code on its profile pages; no plant certifications claimed, consistent with a non-manufacturing trader (per its own profile pages) The drop-shipping model: small-quantity international orders fulfilled from India, useful for buyers who need low MOQs or trial quantities before committing to container-scale procurement Typical markets: Export operations listed to the United States, United Kingdom, Australia, Ireland, and the Philippines (per its profile page), with international drop-ship fulfilment.
4. M Care Exports
Mumbai, Maharashtra (with offices listed in London and Dubai on its site) · 2003 ("since 2003" stated on mcareexports.com; self-claim, verified as present on the site) · Merchant-exporter sourcing manufacturer-direct from WHO-GMP / EU-GMP certified manufacturing lines against purchase orders, with no speculative stock; not a manufacturer
18 therapeutic areas with emphasis on oncology, anti-infectives, cardiovascular, vaccines, and rare/orphan drugs; government tender supply and clinical-trial comparator supply (per mcareexports.com) ISO 9001:2015 (its own certification as a trading entity), CDSCO-licensed exporter, SGS GDP certified, Pharmexcil RCMC holder, FIEO member; WHO-GMP and EU-GMP certifications belong to its source manufacturers' sites, not to M Care itself (all as claimed on mcareexports.com) Documentation-heavy tender support per its site: CTD/eCTD-ready dossiers for MHRA, EMA, SFDA, MoH-UAE, and NAFDAC submissions, WHO-format CoPP and batch CoA supplied with shipments, validated 2-8 C and -25 C cold-chain lanes, and a named account manager on every order; buyers pick them when regulatory paperwork and tender compliance are the bottleneck Typical markets: 46+ active export markets cited on the homepage (company materials also cite 49), spanning the UK, GCC, Africa, and Central Asia.
5. Oddway International
New Delhi (Daryaganj; full address published on its site) · B2B pharmaceutical wholesaler / specialty-access exporter; its site states it operates "within a strictly B2B and case-based framework" with no retail or consumer-facing sales, supplying licensed distributors, hospitals, and institutional buyers
Generic and branded pharmaceuticals with emphasis on oncology, hepatitis C, and HIV; biosimilars, specialty and orphan drugs, plus ayurvedic/herbal lines (per oddwayinternational.com) No certifications prominently listed on the about page reviewed; the site emphasizes regulatory transparency and documentation integrity (per oddwayinternational.com) Specialty-access service menu: named-patient supply, comparator drug sourcing, clinical-trial supply, and third-party exports on a case-by-case B2B basis; buyers pick them for hard-to-source oncology/HCV brands with export paperwork Typical markets: Its site names 15+ countries served, including Russia, China, the USA, the UK, Germany, Japan, South Korea, Vietnam, the Philippines, Singapore, Hong Kong, Nigeria, Egypt, the UAE, and Chile.
6. Rizochem Pharmaceuticals
Aligarh, Uttar Pradesh (address published on rizochem.com); some third-party profiles list Mumbai · 2011 ("Established in 2011" stated on rizochem.com; self-claim, registry confirmation not obtained) · Third-party pharmaceutical wholesaler and exporter of branded and branded-generic medicines plus surgical items (trading, not manufacturing, per its own site)
Oncology/anti-cancer, antivirals, antibiotics, hepatitis, vaccines, HIV range, cardiac medicines, and surgical/medical devices (per rizochem.com) DGFT-registered pharmaceutical exporter; "FDA & Drug Controller of India Approved"; states products follow international quality standards (all as claimed on rizochem.com) Cold-chain export with temperature data loggers and a domestic institutional client list published on its own site (Nuclear Power Corporation of India, Indian Railways hospitals, Department of Atomic Energy); buyers pick them for urgent branded-generic sourcing with temperature-controlled shipping Typical markets: Worldwide export model per its site, with products registered per importing-country norms.
7. Salvavidas Pharmaceutical
Surat, Gujarat (per its own site) · 2015 (incorporated 09 Nov 2015, CIN U74140GJ2015PTC085028 per company registry profile; the CIN year is consistent). No founding year stated on the site itself. · Manufacturer and exporter of finished dosage forms (FDFs) and APIs (its site's own wording); also offers contract manufacturing as a listed service
Antimalarials, analgesics, antibiotics, oncology APIs, and generic medicines across FDFs and APIs (per salvavidaspharma.com) "WHO-GMP & ISO Certified Facilities" (as claimed on salvavidaspharma.com) Combination of manufacturing plus registration support: the site's 500+ product registrations claim and contract-manufacturing offer suit buyers who want a maker rather than a trader, with registration support in their market Typical markets: Claims exports to more than 40 nations across Africa, South-East Asia, Latin America, North America, and the CIS region, with 500+ product registrations worldwide (both per its site).
8. The Indian Pharma (TIP)
Noida, Uttar Pradesh (Sector 62; ITHUM Tower address published on its site), with overseas offices listed in Bulgaria, Belgium, and Hong Kong · Wholesale exporter/distributor and specialized pharmaceutical consulting company, including named-patient import programs and reference-listed drug sourcing for R&D
Oncology, hematology, hepatitis B/C, immunotherapy, transplant medicines, vaccines, and rare-disease/specialty drugs (per theindianpharma.com) No certifications prominently listed on the pages reviewed; the site emphasizes "100% legal and regulated" sourcing from company-authorized distributors (per theindianpharma.com) Small-order friendly terms per its site: no minimum order quantity, special cold-chain packaging, and named-patient access to specialty treatments; buyers pick them for small-quantity specialty and reference-drug sourcing Typical markets: Its site names Europe, the USA, China, Australia, ASEAN, and Latin American countries.
Choosing an Indian pharma exporter, the specific questions.
How do I verify that an Indian pharmaceutical exporter is genuine?
Four checks catch most problems: confirm the Importer-Exporter Code on the DGFT portal, ask for the state Wholesale Drug Licence (Forms 20B and 21B) in the exporting entity's own name, confirm Pharmexcil membership (the RCMC certificate), and ask for the WHO-GMP certificate of the manufacturing site behind your specific product together with a batch Certificate of Analysis. A legitimate exporter produces all four without hesitation.
What does it mean when a trading company says it is WHO-GMP certified?
Strictly, WHO-GMP is granted to a manufacturing site, not to a trading house. When an exporter that does not manufacture displays WHO-GMP, the honest reading is that it sources from WHO-GMP-certified lines. Ask which manufacturing site stands behind your product and request that site's certificate; an exporter who cannot name the site is the red flag.
Should I buy from a manufacturer or a merchant-exporter?
It depends on the order. A manufacturer-exporter gives you factory pricing on its own lines but a catalogue limited to what its plant makes. A merchant-exporter consolidates multiple manufacturers' products in one shipment, one documentation desk and one payment, useful for mixed tenders and multi-molecule orders. Many buyers use both for different purchase types.
What is a CoPP and why does it matter?
The Certificate of Pharmaceutical Product is a WHO-format certificate issued by the exporting country's regulator, in India via CDSCO, for a specific product. Most importing regulators require a legalised CoPP before they register a medicine. If an exporter cannot arrange product-specific CoPPs, your registration file stalls.
Which type of exporter suits small or named-patient quantities?
The specialty-access firms in this guide, GNH India, The Indian Pharma and Oddway International, describe named-patient and small-quantity supply as their core work. Bulk and tender-oriented exporters, including M Care, are generally structured around consolidated commercial quantities, though molecule-level minimums are ultimately set by the manufacturer's batch size.
Where does M Care Exports honestly fit in this list?
M Care is a Mumbai-based merchant-exporter trading since 2003, strongest where an importer, distributor or tender desk needs multi-manufacturer consolidation with the documentation pack (CoPP, CTD dossier, batch CoA) handled by one counterparty. For single-molecule factory-gate pricing a manufacturer-exporter may fit better; we say so because a guide that only recommends its author is not a guide.
Run the checks in this guide on M Care, we'll hold still.
Ask for our IEC, wholesale licence, the WHO-GMP certificates of the manufacturing lines behind your molecule, and a batch CoA. That is the comparison we want to win.